India Plan For Essential-Drug Prices Draws Industry Objection
This article was originally published in PharmAsia News
Executive Summary
India’s health ministry recommendation that prices of essential drugs be based either on the government’s bulk procurement price or the average price of the three lowest-cost drugs has sparked complaints.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.